Company Ticker News January 29, 2022Can AbbVie Beat Pfizer in the Atopic Dermatitis Market? 0 0 Share
Company Ticker News January 29, 2022Value, Growth, or Momentum: What Kind of Investor are You? 0 0 Share
Company Ticker News January 24, 2022AbbVie's (ABBV) Skyrizi Gets FDA Nod for Psoriatic Arthritis 0 0 Share
Press Release January 22, 2022U.S. FDA Approves Second Indication for SKYRIZI® (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis 0 0 Share
Company Ticker News January 21, 2022Top Biotech Stocks To Buy Now? 5 For Your Late January Watchlist 0 0 Share
